Asianet NewsableAsianet Newsable

‘Watershed moment in India’s battle against COVID-19’, says Harsh Vardhan

Covishield, the vaccine developed by Oxford and AstraZeneca, is being manufactured for India and other countries by the Pune-based Serum Institute of India, while Coxavin is India’s first domestic Covid-19 vaccine made by the Hyderabad-based Bharat Biotech.

Watershed moment in India's battle against COVID-19, says Harsh Vardhan-dnm
Author
New Delhi, First Published Jan 3, 2021, 5:40 PM IST

New Delhi: Welcoming the final approval for Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease (Covid-19) for emergency use ,Union health minister Dr Harsh Vardhan on Sunday said it was a watershed moment in India’s battle against Covid-19 under the leadership of Prime Minister Narendra Modi.

"A watershed moment in India’s famed battle against COVID-19 under the charismatic leadership of Hon’ble PM Sh Narendra Modi Ji! Our wait for COVID19 vaccine is over with COVISHIELD from @SerumInstIndia & COVAXIN from @BharatBiotech approved for emergency use in India," said Harsh Vardhan.

He added, "These vaccines are a fitting tribute to our corona warriors! My heartfelt gratitude to all healthcare professionals & frontline workers for their exemplary efforts during these unprecedented times. Congratulations to all the scientists & researchers for their untiring efforts."

The Health Minister also said, "It's now time to reap the benefits of the robust supply chain infrastructure we’ve put in place for quick & equitable distribution of the vaccine. Urge all citizens to entrust the stringent protocols followed for ensuring safety, efficacy & immunogenicity of the approved vaccines.

Covishield, the vaccine developed by Oxford and AstraZeneca, is being manufactured for India and other countries by the Pune-based Serum Institute of India, while Coxavin is India’s first domestic Covid-19 vaccine made by the Hyderabad-based Bharat Biotech.

Follow Us:
Download App:
  • android
  • ios